Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135895) titled 'The ArtixASCEND Study' on Aug. 13.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Inari Medical

Condition: Acute Lower Limb Arterial Occlusion

Intervention: Device: Artix Thrombectomy System

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: November 1, 2025

Target Sample Size: 330

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07135895

Published by HT Digital Content Services with permission from Health Daily Digest....